LifeMD reported a 13% year-over-year increase in total revenue to $60.2 million, with adjusted EBITDA rising by 20% to $5.1 million.
Telehealth revenue specifically grew by 18% to $47.3 million, while telehealth adjusted EBITDA saw a 30% increase to $2.9 million.
The company paid off all outstanding debt during the quarter and divested its majority stake in WorkSimpli, focusing on telehealth and pharmacy services.
Financial Growth
Total revenue increased by 13% year-over-year, reaching $60.2 million, with adjusted EBITDA up 20% to $5.1 million.
Strategic Shift
LifeMD divested its majority stake in WorkSimpli, becoming a pure-play telehealth and pharmacy platform, positioning itself for future growth.
Diversification Efforts
LifeMD launched new services in women's health, men's health, psychiatry, and strengthened its regulatory approval for personalized therapies.
- The company's strategic divestiture of WorkSimpli and focus on core telehealth and pharmacy services is set to enhance its financial position and accelerate growth in 2026.
- New launches in diverse health sectors indicate a proactive approach in expanding service offerings and market reach.
LifeMD's strong financial results, strategic divestiture, and focus on expanding healthcare services showcase its commitment to growth and innovation in the telehealth industry.